April 24, 2025 Siren Biotechnology at UCSF is developing the first universal AAV-based gene therapy for solid tumors, starting with brain cancers like high-grade gliomas. To fund its upcoming first-in-human clinical trial, Siren launched a community investment round via Wefunder, seeking $50,000–$5 million. Its lead therapy, SRN-101, combines gene therapy with cytokine immunotherapy and has […]
April 30, 2025 This USA Today article highlights singer Michael Bolton’s battle with glioblastoma. Diagnosed in December 2023, Bolton underwent two brain surgeries and completed radiation and chemotherapy, with his most recent scan in April showing no cancer. The piece sheds light on the grim statistics—an average survival of just eight months and a five-year […]